Related Experiment Videos
Congenital hypothyroidism: age at start of treatment versus outcome
Insights
Early treatment for congenital hypothyroidism (CH) before one month of age preserves normal intelligence. Delayed treatment, especially after three months, leads to significant neurological damage and intelligence loss.
Area of Science:
- Pediatric Endocrinology
- Neurodevelopmental Disorders
- Congenital Disorders
Background:
- Congenital hypothyroidism (CH) is a condition present at birth that can impair neurodevelopment.
- Untreated CH can lead to irreversible cognitive deficits and neurological abnormalities.
- Timely intervention is crucial for optimal outcomes in infants with CH.
Purpose of the Study:
- To evaluate the impact of treatment timing on neurological and psychometric outcomes in patients with congenital hypothyroidism.
- To determine the critical window for initiating treatment to prevent cognitive impairment.
- To assess the relationship between early intervention and neurological damage in CH.
Main Methods:
- Neurological and psychometric assessments were performed on 27 patients with congenital hypothyroidism.
- A control group of 7 healthy siblings was included for psychometric evaluation.
- Patient treatment initiation timing was categorized as before 1 month or after 3 months of age.
Main Results:
- Intelligence remained within the normal range when treatment for CH began before 1 month of age.
- Delayed treatment (after 3 months) was associated with significant loss of intelligence potential.
- Neurological damage appeared to have prenatal origins but worsened with delayed treatment.
Conclusions:
- Initiating treatment for congenital hypothyroidism before 1 month of age is critical for preserving normal intelligence.
- Delayed treatment beyond 3 months results in progressive and more severe neurological injury.
- Early diagnosis and intervention are paramount for mitigating long-term neurodevelopmental consequences of CH.
Abstract:
We studied 27 patients with congenital hypothyroidism by neurological and psychometric methods. 7 healthy siblings served as a control group for the psychometric evaluation. In 7 patients treatment had been started before the age of 1 month and in 10 patients after the age of 3 months. Our findings suggest that the progressive loss of intelligence potential starts from birth but if treatment is begun before the age of 1 month, then intelligence remains within normal range. The neurological damage seems to originate partly before birth, but more serious injuries arise if treatment is delayed beyond the age of 3 months.